Health Update: Vanessa Trump Reports Clear Breast Cancer Tests

Vanessa Trump has confirmed she is free of breast cancer, a condition diagnosed earlier this year. The 48-year-old shared the update in a video released on Friday, stating that her recent test results 'came back clear, so I'm finally cancer-free.'

The news surfaced during October, which is designated as Breast Cancer Awareness Month. The clip was posted to the Instagram account of Kai Trump, Vanessa’s 19-year-old daughter. In the video, mother and daughter discuss the disease and prevention strategies. A caption accompanying the post noted that the short clip serves as a preview for a longer interview scheduled for release on Saturday. That extended video will feature Dr. Nicole Saphier, a medical expert who joins the conversation to discuss early detection and support for patients.

Vanessa Trump first received her diagnosis in April. She made the news public in May, revealing that she had undergone surgery and was collaborating with medical professionals on a treatment plan. The family has five children together. Vanessa Trump and Donald Trump Jr. separated in 2018. In the last year, she announced she began dating Tiger Woods, the professional golfer.

The social media post generated immediate engagement. It collected more than 20,000 likes and hundreds of comments within hours. Among the public figures responding was Mary Millben, an American singer and media personality. The comments offered support and good wishes to Trump and her family.

Medical statistics from the American Cancer Society provide context for the diagnosis. The organization reports that the average risk for a woman in the United States developing breast cancer is approximately 1 in 8, or 13%. The disease represents 30% of all new female cancers diagnosed annually. Standard treatments include surgery, which cures most cases. For remaining disease, chemotherapy, radiotherapy, and endocrine therapy reduce long-term risk. Recent advancements in targeted therapies and precise radiotherapy continue to improve outcomes for early-stage breast cancer.